Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β. [electronic resource]
Producer: 20191210Description: 154-160 p. digitalISSN:- 1090-2104
- Alzheimer Disease -- chemically induced
- Animals
- Glucagon-Like Peptide-1 Receptor -- metabolism
- Glucagon-Like Peptides -- analogs & derivatives
- Glycogen Synthase Kinase 3 beta -- metabolism
- Hypoglycemic Agents -- therapeutic use
- Immunoglobulin Fc Fragments -- therapeutic use
- Intermediate Filaments -- metabolism
- Male
- Maze Learning -- drug effects
- Memory -- drug effects
- Memory Disorders -- drug therapy
- Mice, Inbred C57BL
- Phosphorylation -- drug effects
- Recombinant Fusion Proteins -- therapeutic use
- Signal Transduction -- drug effects
- Streptozocin
- tau Proteins -- metabolism
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.